Cytomegalovirus infection trials in China

In China 9 Also abroad 66

9 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
CMV-CMI in csCMVi After HSCT
Where
Suzhou
Age
18 years and over
People
40
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07688759
Phase 4Taking people
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
Where
Beijing, Hohhot, Jingzhou, Nanchang, Shijiazhuang, Wenzhou, Wuhan, Zhengzhou
Age
18 years and over
People
120
Run by
WeiShi
See details and how to joinNCT07569653
Phase 3Taking people
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Where
Beijing, Guangzhou, Shanghai, Shenzhen, Tianjin
Age
Up to 17 years
People
80 worldwide
Run by
Takeda
See details and how to joinNCT05319353 · EU 2023-508988-73-00
Phase 3Taking people
Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
Where
Shanghai
Age
18 years to 75 years
People
218
Run by
Ruijin Hospital
See details and how to joinNCT07511127
No phaseTaking people
Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT
Where
Suzhou
Age
18 years and over
People
330
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT06812598
Phase 4Taking people
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients
Where
Xi’an
Age
18 years and over
People
290
Run by
First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT07266467
No phaseNot yet taking people in China
A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection
Where
Tianjin
Age
12 years and over
People
17
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07141095
Phase 2Taking people
ATG Individualized Dosing Model in URD-PBSCT.
Where
Beijing
Age
14 years to 65 years
People
30
Run by
Chinese PLA General Hospital
See details and how to joinNCT06572462
Early phase 1Taking people
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Where
Tianjin
Age
2 years to 80 years
People
15
Run by
Tianjin Medical University
See details and how to joinNCT05911503